Literature DB >> 16470223

Dissection of the NF-kappaB signalling cascade in transgenic and knockout mice.

M Pasparakis1, T Luedde, M Schmidt-Supprian.   

Abstract

Studies in transgenic and knockout mice have made a major contribution to our current understanding of the physiological functions of the NF-kappaB signalling cascade. The generation and analysis of mice with targeted modifications of individual components of the NF-kappaB pathway tremendously advanced our knowledge of the roles of the NF-kappaB proteins themselves, and also of the many activators and negative regulators of NF-kappaB. These studies have highlighted the complexity of the NF-kappaB system, by revealing the multiple interactions, redundancies, but also diverse functions, performed by the different molecules participating in the regulation of NF-kappaB signalling. Furthermore, inhibition or enforced activation of NF-kappaB in transgenic mice has uncovered the critical roles that NF-kappaB plays in the pathogenesis of various diseases such as liver failure, diabetes and cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16470223     DOI: 10.1038/sj.cdd.4401870

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  57 in total

1.  Inhibitor of growth-4 promotes IkappaB promoter activation to suppress NF-kappaB signaling and innate immunity.

Authors:  Andrew H Coles; Hugh Gannon; Anna Cerny; Evelyn Kurt-Jones; Stephen N Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

Review 2.  Tenuous paths in unexplored territory: From T cell receptor signaling to effector gene expression during thymocyte selection.

Authors:  Lie Wang; Yumei Xiong; Rémy Bosselut
Journal:  Semin Immunol       Date:  2010-10       Impact factor: 11.130

3.  NF-kappaB p50 plays distinct roles in the establishment and control of murine gammaherpesvirus 68 latency.

Authors:  Laurie T Krug; Christopher M Collins; Lisa M Gargano; Samuel H Speck
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

Review 4.  NF-κB control of T cell development.

Authors:  Steve Gerondakis; Thomas S Fulford; Nicole L Messina; Raelene J Grumont
Journal:  Nat Immunol       Date:  2014-01       Impact factor: 25.606

Review 5.  Emerging roles for the non-canonical IKKs in cancer.

Authors:  R R Shen; W C Hahn
Journal:  Oncogene       Date:  2010-11-01       Impact factor: 9.867

6.  Tumor-suppressive microRNA-497 targets IKKβ to regulate NF-κB signaling pathway in human prostate cancer cells.

Authors:  Xiang-Jie Kong; Liu-Jian Duan; Xiao-Qiang Qian; Ding Xu; Hai-Long Liu; Ying-Jian Zhu; Jun Qi
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

7.  Drosophila Rel proteins are central regulators of a robust, multi-organ immune network.

Authors:  Nina Matova; Kathryn V Anderson
Journal:  J Cell Sci       Date:  2010-02-15       Impact factor: 5.285

8.  A splicing variant of NME1 negatively regulates NF-κB signaling and inhibits cancer metastasis by interacting with IKKβ.

Authors:  Dong-Joo You; Cho Rong Park; Hyun Bok Lee; Mi Jin Moon; Ju-Hee Kang; Cheolju Lee; Seong-Hyun Oh; Curie Ahn; Jae Young Seong; Jong-Ik Hwang
Journal:  J Biol Chem       Date:  2014-05-08       Impact factor: 5.157

9.  Focal adhesion kinase mediates the interferon-gamma-inducible GTPase-induced phosphatidylinositol 3-kinase/Akt survival pathway and further initiates a positive feedback loop of NF-kappaB activation.

Authors:  Zhen Liu; Huifang M Zhang; Ji Yuan; Travis Lim; Alhousseynou Sall; Gregory A Taylor; Decheng Yang
Journal:  Cell Microbiol       Date:  2008-04-28       Impact factor: 3.715

Review 10.  Cell penetrating peptide inhibitors of nuclear factor-kappa B.

Authors:  J S Orange; M J May
Journal:  Cell Mol Life Sci       Date:  2008-11       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.